Act of Congress, Inflammation, Bigger than Berkshire and a "Trump Trade"
| |
| | WEEKEND UPDATE February 4-5, 2017 |
| |
| Greetings!
| | Ready to catch up on everything you missed in Gumshoe-land this week? The most-discussed teaser pitch this week was from Laissez Faire Letter, and they're talking up the potential to make crazy gains like 1,000% on "Act of Congress #5748" -- with those gains coming as soon as March 16, when this Act hits an important deadline of some kind. So what are they talking about? Just click below to... |
| |
|
The Greatest Commodity Shortage in History It's no secret the world faces shortages in many commodities. The world's diminishing supply of everything from cocoa to coffee... lithium to lumber... phosphate to plutonium... silver to sugar... is of great concern. But there's an even bigger and more imminent commodity shortage at hand that no one is talking about. Details here... |
|
| Advertisement
|
| |
| We started the week with a look at Mark Skousen's "Trump Trade" for his new 1600 Alert... an infrastructure stock, naturally. And yes, it has a connection with "the wall" that we keep hearing about... so what is it? Details here.
The Motley Fool suggested that their favored stock "could be bigger than Buffett's Berkshire Hathaway"... which is always a good way to get yourself some attention. What's the stock they're talking about? Thinkolator sez... click here for that answer.
Doc Gumshoe also popped by with a look at inflammation -- is it really the archvillain? Will stopping it bring miracle cures? See what he thinks in his note here.
And the Irregulars were kept busy again this week, starting with Dr. KSS's "live blog" notes from an investor conference and finishing up with a couple buys I made and the final installment of my annual review... all of that's in the Irregulars Corner... |
| |
|
| Disclaimer: Nothing in this email or in the linked articles should be considered to be individual investment advice -- we can't tell you what you should do with your money, we can just share our opinions and perspective. Our authors try to use reliable information sources but also make mistakes of both fact and judgement on occasion, so all assertions should be checked and confirmed. You should speak with your financial advisor and understand everything fully before committing money to any investment.
Most issues of this email newsletter include advertising, and it should not be assumed that the presence of an advertisement means that the product or service advertised is endorsed by Stock Gumshoe or the author. For full disclaimers, disclosure information, and privacy policies please see the prominent links at the bottom of each page at StockGumshoe.com.
If you wish to unsubscribe to these mailings, there are links at both the bottom and top of this email that you can use to do so permanently and safely, we have no wish to email people who don't want to receive these messages. Please note that unsubscribing using the link below applies only to receiving emails, if you are a member of the Stock Gumshoe Irregulars that membership will not automatically change or be canceled. Please contact us if you need to change a paid membership.
|
| |
|
